# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 6r2w:L (1.25) | BS01 | BGC | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
2 | 6r2w:L (1.25) | BS02 | XYS | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
3 | 6r2w:L (1.25) | BS03 | XYS | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
4 | 6r2w:L (1.25) | BS04 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
5 | 6r2w:L (1.25) | BS05 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
6 | 6r2w:L (1.25) | BS06 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
7 | 6r2w:L (1.25) | BS07 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
8 | 6r2w:L (1.25) | BS08 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
9 | 6r2w:L (1.25) | BS09 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
10 | 6r2w:L (1.25) | BS10 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 | |
11 | 6r2w:L (1.25) | BS11 | FUC | 3.4.21.21 | GO:0005509 ... | P08709 | 31801825 |